Table 6.
Hazard ratios of vascular access type on endpoints according to age
VA abandonment | All-cause mortality | Maturation failure | ||||
---|---|---|---|---|---|---|
HR (95% CI) | P value | HR (95% CI) | P value | OR (95% CI) | P value | |
Age < 80 years | ||||||
VA type (ref. RC AVF) | 0.019 | 0.015 | ||||
BC AVF | 0.55 (0.18–1.70) | 0.299 | 0.68 (0.39–1.20) | 0.184 | ||
AVG | 2.71 (1.09–6.73) | 0.032 | 0.23 (0.09–0.65) | 0.005 | ||
Age ≥ 80 years | ||||||
VA type (ref. RC AVF) | 0.002 | |||||
BC AVF | 3.47 (1.34–9.01) | 0.011 | ||||
AVG | 6.30 (2.29–17.35) | < 0.001 |
Adjusted for age, sex, BMI, systolic blood pressure, Hemoglobin, cholesterol, albumin, calcium, phosphorus, DM, CAD, PVD, CVD, CHF, VA type, history of CVC, duplex U/S findings (BA diameter, BA flow, Cephalic vein diameter, Cephalic vein flow)
AVF arteriovenous fistula, AVG arteriovenous graft, BA brachial artery, BMI body mass index, BC brachiocephalic, CAD coronary artery disease, CVC central vein catheter, CVD cerebrovascular disease, CHF congestive heart failure, DM diabetes mellitus, PVD peripheral vascular disease, PSV peak systolic velocity, PTA percutaneous transluminal angioplasty, RC radiocephalic, U/S ultrasonography, HR hazard ratio, CI confidence index, OR odds ratio